Full-Time

Director – Hta

Value & Evidence, Hv&E, Vaccine Pipeline, Lyme Disease Vaccine

Posted on 2/3/2025

Pfizer

Pfizer

10,001+ employees

Develops and manufactures biopharmaceutical products

Social Impact
Biotechnology
Healthcare

Compensation Overview

$169.7k - $282.9kAnnually

+ Bonus

Senior, Expert

No H1B Sponsorship

Cambridge, MA, USA + 9 more

More locations: Tampa, FL, USA | Bothell, WA, USA | San Bruno, CA, USA | Phoenixville, PA, USA | Dorking, UK | La Jolla, San Diego, CA, USA | Highland Park, IL, USA | Groton, CT, USA | New York, NY, USA

Position is hybrid and will require to work from site 2 to 3 days per week. NOT Eligible for Relocation Package.

Category
Public Health
Biology & Biotech

You match the following Pfizer's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Graduate degree minimum required (i.e., MBA, MPH, MSc or PharmD / PhD)
  • 7+ years of experience required with MSc/MPH/MBA degree
  • 5+ years of experience required with PharmD/PhD in HEOR or relevant related fields (health economics, epidemiology, health services research, or other research-focused public health field)
  • Demonstrated in depth understanding of fundamental health services research methods and tools including but not limited to: Health economics, Cost-effectiveness / budgetary impact modeling, Patient reported outcomes measures, Real world evidence studies, Epidemiology, Statistics
  • Strong interpersonal skills and evidence of teamwork in a matrix environment
  • Ability to understand, synthesize, and summarize complex topics is required
  • Excellent oral and written English communication skills are required
  • Demonstrated ability to assess anticipated value for projects/programs to ensure alignment to business priorities and prioritize accordingly
  • An “execution mindset” focused on getting things done quickly and simply
  • Demonstrated ability to manage multiple projects involving complex processes, significant budget, competing deadlines, and rapidly shifting priorities in a compliant manner
Responsibilities
  • Lead development and execution of strategic HV&E activities to support launch preparation for the late-stage Lyme Disease Vaccine
  • Maintain awareness of scientific developments, new and innovative methodologies, and trends in the evolving healthcare landscape to ensure incorporation into research plans
  • Lead development of evidence generation strategy to quantify unmet medical need to demonstrate the value of Lyme Disease Vaccine, in collaboration with medical, GASP, and Local markets
  • Generate HV&E deliverables needed for clinical development, regulatory interactions, and internal governance milestones
  • Lead development of value propositions for payers, policymakers, healthcare providers, consumers, and other stakeholders
  • Oversee development of launch ready tools and health economic models to explain the value of the vaccine to stakeholders
  • Collaborate with internal asset teams and external experts on the conception, design, specification, and format of health economic models
  • Lead quality assurance and stress testing of economic models, as well as comparisons with other published modeling efforts
  • Prepare and deliver presentations and reports communicating health economic results to various stakeholders
  • Lead the design, implementation, and management of HV&E and real-world evidence studies from concept through publication
  • Generate new evidence to measure burden of disease (disease incidence, treatment patterns, costing, etc.) using real world data and other data sources
  • Execute and manage research projects with external collaborators and vendors to ensure timely completion and quality of deliverables as well as budget and legal compliance
  • Generate peer-reviewed publications to communicate study findings in scientific channels in alignment with the product publication strategy
  • Set the ambition and vision for value-based access to vaccines
  • Develop effective processes and ways of working to support collaboration with key internal stakeholder groups (e.g., medical, clinical, commercial, etc.)
  • Identify new opportunities for value creation based on an understanding of health care systems and the potential benefits of Pfizer vaccines
  • Support development of innovative approaches to evidence generation that meet payer needs and integrate these with the needs of other customers
  • Prepare for value story and cost effectiveness modeling content to support vaccine technical committee recommendations
Desired Qualifications
  • Knowledge and understanding of drug development process
  • Knowledge and experience in vaccines is strongly preferred
  • Experience with VTC and HTA organizations such as ACIP, NICE, JCVI, etc.
  • Proven ability to develop strong partnerships across multiple functions within a large organization

Pfizer focuses on creating and producing healthcare products, particularly medicines and vaccines. The company conducts extensive research and development to discover new treatments, which are then manufactured and sold globally. Pfizer's products include vaccines, cancer treatments, and other specialized medications. A key aspect of Pfizer's operations is its collaboration with BioNTech to develop a vaccine for COVID-19, showcasing its role in addressing public health challenges. Unlike many competitors, Pfizer emphasizes not only the development of new drugs but also the distribution of vaccines to underserved communities. The company's goal is to enhance public health by expanding its range of effective treatments and ensuring access to its products worldwide.

Company Stage

IPO

Total Funding

$3.8B

Headquarters

New York City, New York

Founded

1849

Simplify Jobs

Simplify's Take

What believers are saying

  • Starboard Value's $1 billion stake may drive strategic changes and increase shareholder value.
  • Pfizer's investment in fibrosis treatments expands its therapeutic areas.
  • Involvement in protein modification research diversifies Pfizer's treatment offerings.

What critics are saying

  • Slowdown in COVID-19 vaccine demand impacts Pfizer's revenue streams.
  • Activist investor Starboard Value may influence Pfizer's strategic decisions.
  • Emerging biotech companies pose a threat to Pfizer's market share in immunotherapy.

What makes Pfizer unique

  • Pfizer's partnership with BioNTech led to a highly effective COVID-19 vaccine.
  • Pfizer invests in AI disease models, enhancing predictive insights for drug development.
  • Pfizer's oncology portfolio is strengthened by investments in TCR-based immunotherapies.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Paid Vacation

Paid Sick Leave

Paid Holidays

Hybrid Work Options

Relocation Assistance